Ambruso, S. L., & Weir, M. R. The Path to Progress: Glucagon-like Peptide 1 Agonists, Individualized Care, and Overcoming Goal-Directed Medical Therapy Barriers in Diabetes and CKD. Elsevier.
Chicago Style (17th ed.) CitationAmbruso, Sophia L., and Matthew R. Weir. The Path to Progress: Glucagon-like Peptide 1 Agonists, Individualized Care, and Overcoming Goal-Directed Medical Therapy Barriers in Diabetes and CKD. Elsevier.
MLA (9th ed.) CitationAmbruso, Sophia L., and Matthew R. Weir. The Path to Progress: Glucagon-like Peptide 1 Agonists, Individualized Care, and Overcoming Goal-Directed Medical Therapy Barriers in Diabetes and CKD. Elsevier.
Warning: These citations may not always be 100% accurate.